Arcutis Biotherapeutics, Inc.

ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001787306

Price chart

Open-market purchases and sales by ARQT insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 18, 20264:17 PM ETSep 16, 2026Matsuda MasaruSee RemarksSSaleCommon Stock−3.67K$25.0009−$91.85K112.51K−3.2%SEC10b5-1
Sep 17, 20264:06 PM ETSep 15, 2026Welgus Howard G.DirectorSSaleCommon Stock−4.73K$24.18−$114.37K35.84K−11.7%SEC10b5-1
Sep 10, 20267:24 PM ETSep 8, 2026Matsuda MasaruSee RemarksSSaleCommon Stock−9.99K$25.0261−$249.99K116.18K−7.9%SEC10b5-1
Aug 28, 20265:40 PM ETAug 27, 2026Curran TerrieDirectorSSaleCommon Stock−38.2K$25.0294−$956.12K23.53K−61.9%SEC
Aug 24, 20264:19 PM ETAug 20, 2026Curran TerrieDirectorSSaleCommon Stock−1.07K$26.0376−$27.91K23.53K−4.4%SEC

The largest institutional positions in ARQT at the end of Q2 2026.

Institutions holding ARQT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
SUVRETTA CAPITAL MANAGEMENT, LLC12,437,000$326.1M6.85%+110,000+0.9%Added
BlackRock, Inc.10,545,466$276.5M0.00%+1,345,055+14.6%Added
Frazier Life Sciences Management, L.P.9,874,511$258.91M5.64%00.0%Unchanged
Rubric Capital Management LP8,271,577$216.88M1.99%00.0%Unchanged
Polar Capital Holdings Plc6,606,945$173.23M0.49%+940,005+16.6%Added